NeuTrexin® (Trimetrexate)

Company
MedImmune Oncology
Use
Treatment for infections due to toxoplasma gondii and pneumocystis carinii in immunocompromised patients, including patients with AIDS
Features
Available as a sterile lyophilized powder
NIH Contribution
Active compound Trimetrexate used as antiparasitic agent in AIDs treatment
Approval Type
FDA
HHS Institute/Agency
NCI
Inventor(s)
C. Allegra, B. Chabner, J. Drake
Year
1994
Tech Cat
Therapeutic

Request More Info

L-060-1990